Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 1.00 |
| ▸ | FNTB | P49356 | 18/20 | 1.00 |
| ▸ | PGGT1B | P53609 | 14/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7937545 | 1.00 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL2352916 | 1.00 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| Hydrochloric Acid SCHEMBL7939170 | 0.99 | FNTA (0.98) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| Hydrochloric Acid SCHEMBL7939168 | 0.99 | FNTA (0.98) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL12991980 | 0.93 | FNTA (0.87) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL12992215 | 0.93 | FNTA (0.87) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL12991908 | 0.92 | FNTA (0.88) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL12991786 | 0.92 | FNTA (0.88) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7927571 | 0.91 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 | |
| SCHEMBL7939534 | 0.91 | FNTA (1.00) | FNTAFNTBPGGT1BKCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080153758-A1 | Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease | EXONHIT THERAPEUTICS SA (FR) | 2008-06-26 | — | — | US | claimed |
| EP-1811984-A1 | COMPOUNDS WHICH INHIBITS PROTEIN PRENYLATION E.G. GERANYLGERANYLTRANSFERASE OR FARNESYLTRANSFERASE INHIBITORS FOR TREATING PARKINSON'S DISEASE | Exonhit Therapeutics SA (FR) | 2007-08-01 | — | — | EP | claimed |
| WO-2006051423-A1 | COMPOUNDS WHICH INHIBITS PROTEIN PRENYLATION E.G. GERANYLGERANYLTRANSFERASE OR FARNESYLTRANSFERASE INHIBITORS FOR TREATING PARKINSON’S DISEASE | EXONHIT THERAPEUTICS SA (FR) | 2006-05-18 | — | — | WO | claimed |
| EP-1656931-A1 | Compounds which inhibits protein prenylation ( e.g. geranylgeranyltransferase or farnesyltransferase inhibitors) for treating Parkinson's disease | Exonhit Therapeutics SA (FR) | 2006-05-17 | — | — | EP | claimed |
| CN-122029269-A | Powder supply device | 富士胶片株式会社 | 2026-05-12 | — | — | CN | disclosed |
| EP-4682240-A1 | BIOPROCESS SOLUTION PREPARATION METHOD AND MIXING CONTAINER | FUJIFILM Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20260002119-A1 | METHOD FOR PREPARING BIOPROCESS SOLUTION AND MIXING CONTAINER | FUJIFILM CORP (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20250211257-A1 | FAST COMBINED CHASE AND GMD DECODING OF GENERALIZED REED-SOLOMON CODES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-26 | — | — | US | disclosed |
| WO-2025126651-A1 | SOLUTION PREPARATION DEVICE, METHOD FOR OPERATING SOLUTION PREPARATION DEVICE, AND PROGRAM FOR OPERATING SOLUTION PREPARATION DEVICE | 富士フイルム株式会社 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025070314-A1 | POWDER SUPPLY DEVICE | 富士フイルム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| CN-119060579-A | Special solvent for photocuring high-fluorine-content transparent coating and preparation method thereof | 中昊北方涂料工业研究设计院有限公司 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024190822-A1 | BIOPROCESS SOLUTION PREPARATION METHOD AND MIXING CONTAINER | 富士フイルム株式会社 | 2024-09-19 | — | — | WO | disclosed |
| WO-2011088126-A2 | TREATMENT OF VIRAL INFECTION WITH PRENYLTRANSFERASE INHIBITORS | EIGER BIOPHARMACEUTICALS, INC. (US) | 2011-07-21 | — | — | WO | disclosed |
| US-20080153758-A1 | Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease | EXONHIT THERAPEUTICS SA (FR) | 2008-06-26 | — | — | US | disclosed |
| US-20080153758-A1 | Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease | EXONHIT THERAPEUTICS SA (FR) | 2008-06-26 | — | — | US | disclosed |
| US-20080153758-A1 | Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease | EXONHIT THERAPEUTICS SA (FR) | 2008-06-26 | — | — | US | disclosed |
| EP-1811984-A1 | COMPOUNDS WHICH INHIBITS PROTEIN PRENYLATION E.G. GERANYLGERANYLTRANSFERASE OR FARNESYLTRANSFERASE INHIBITORS FOR TREATING PARKINSON'S DISEASE | Exonhit Therapeutics SA (FR) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006051423-A1 | COMPOUNDS WHICH INHIBITS PROTEIN PRENYLATION E.G. GERANYLGERANYLTRANSFERASE OR FARNESYLTRANSFERASE INHIBITORS FOR TREATING PARKINSON’S DISEASE | EXONHIT THERAPEUTICS SA (FR) | 2006-05-18 | — | — | WO | disclosed |
| EP-1656931-A1 | Compounds which inhibits protein prenylation ( e.g. geranylgeranyltransferase or farnesyltransferase inhibitors) for treating Parkinson's disease | Exonhit Therapeutics SA (FR) | 2006-05-17 | — | — | EP | disclosed |
| WO-2001017992-A1 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2001-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153758-A1 | Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's Disease | FNTA, GGPS1, FNTB | FNTA 1/4885FNTB 3/4885PGGT1B 126/4885 |
| US-20260002119-A1 | METHOD FOR PREPARING BIOPROCESS SOLUTION AND MIXING CONTAINER | SET, BCAS2, BMP2 | FNTA 3329/4885FNTB 3242/4885PGGT1B 4489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.